Your browser doesn't support javascript.
loading
Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy.
Pan, Yuanwei; Wu, Xianjia; Liu, Lujie; Zhao, Chenchen; Zhang, Jing; Yang, Shengren; Pan, Pan; Huang, Qinqin; Zhao, Xing-Zhong; Tian, Rui; Rao, Lang.
Afiliación
  • Pan Y; The Research and Application Center of Precision Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450014, China.
  • Wu X; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
  • Liu L; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
  • Zhao C; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
  • Zhang J; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
  • Yang S; Key Laboratory of Artificial Micro- and Nano-Structures of Ministry of Education, School of Physics and Technology, Wuhan University, Wuhan, 430072, China.
  • Pan P; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
  • Huang Q; Key Laboratory of Artificial Micro- and Nano-Structures of Ministry of Education, School of Physics and Technology, Wuhan University, Wuhan, 430072, China.
  • Zhao XZ; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China.
  • Tian R; The First Affiliated Hospital of Jinan University, Guangzhou, 510632, China.
  • Rao L; The Research and Application Center of Precision Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450014, China.
Adv Healthc Mater ; 13(13): e2400068, 2024 05.
Article en En | MEDLINE | ID: mdl-38320299

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Vacunas contra el Cáncer / Inmunoterapia Límite: Animals / Female / Humans Idioma: En Revista: Adv Healthc Mater Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Vacunas contra el Cáncer / Inmunoterapia Límite: Animals / Female / Humans Idioma: En Revista: Adv Healthc Mater Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania